These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
27. Iron acquisition by Pseudomonas aeruginosa in the lungs of patients with cystic fibrosis. Lamont IL; Konings AF; Reid DW Biometals; 2009 Feb; 22(1):53-60. PubMed ID: 19130260 [TBL] [Abstract][Full Text] [Related]
28. The approach to Pseudomonas aeruginosa in cystic fibrosis. Bendiak GN; Ratjen F Semin Respir Crit Care Med; 2009 Oct; 30(5):587-95. PubMed ID: 19760546 [TBL] [Abstract][Full Text] [Related]
29. [What previous deductions can be used for optimizing analysis of bronchial secretions in cystic fibrosis?]. Pin I; Pilenko C; Gout JP; Bost M Rev Mal Respir; 2003 Apr; 20(2 Pt 2):S63-7. PubMed ID: 12910136 [No Abstract] [Full Text] [Related]
30. Risk assessment of Pseudomonas aeruginosa in water. Mena KD; Gerba CP Rev Environ Contam Toxicol; 2009; 201():71-115. PubMed ID: 19484589 [TBL] [Abstract][Full Text] [Related]
31. Cystic fibrosis infections: treatment strategies and prospects. George AM; Jones PM; Middleton PG FEMS Microbiol Lett; 2009 Nov; 300(2):153-64. PubMed ID: 19674113 [TBL] [Abstract][Full Text] [Related]
38. Basic science for the chest physician: Pseudomonas aeruginosa and the cystic fibrosis airway. Williams HD; Davies JC Thorax; 2012 May; 67(5):465-7. PubMed ID: 22382597 [No Abstract] [Full Text] [Related]
39. [How should initial colonization by Pseudomonas aeruginosa be treated in patients with cystic fibrosis?]. David V Rev Mal Respir; 2003 Apr; 20(2 Pt 2):S113-7. PubMed ID: 12910143 [No Abstract] [Full Text] [Related]
40. [Respiratory infection in cystic fibrosis: burden of illness in the progression of cystic fibrosis, previous deductions for the microbiological study of bronchial secretions and clinical criteria of infection]. Thumerelle C Rev Mal Respir; 2003 Apr; 20(2 Pt 2):S37-48. PubMed ID: 12910133 [No Abstract] [Full Text] [Related] [Previous] [New Search]